Study finds less invasive tests could still detect serious infections in infants.

How the U-M turned a former pharmaceutical research campus into a thriving hub of innovation.

Three early-stage cancer drug projects receive pilot grants to help them advance from the bench toward the bedside.

Michigan Medicine study investigates the effects of significant mitral regurgitation on patients after the implantation of a left ventricular assist device.

Now with recreational marijuana legalized in Michigan, it’s easier for glaucoma patients to substitute traditional treatment methods for a joint. But does it..

How unexpected awakenings in dementia patients might shed new light on the disease, according to University of Michigan researcher and colleagues

Hesitation to put MS patients on the operating table, due to relapse risk, may have physicians delaying important surgeries unnecessarily.

American Heart Association funding will allow Michigan Medicine to establish a leading research and training program with a focus on preventing brain damage caused by out-of-hospital cardiac arrest.

U-M researchers identify a potential treatment for non-alcoholic fatty liver disease.

The largest study of its kind finds societal factors and access to quality care, rather than genetics, underlies higher prostate cancer mortality rates for black men.

New research shows that a combination of two immune-system factors could open up new avenues for treating diabetes and obesity.

A new study finds that U-M-designed compounds led to significantly smaller, slower-growing tumors.

Researchers identify genetic variants that lead to a severe developmental syndrome. The findings could mean better screening and diagnosis for patients with inherited syndromes.

Researchers cause a lupus-like disease in mice by amplifying the amount of a single “master regulator” factor — suggesting both a root cause for known differences between the sexes and a target for new treatments.

A new study examined APS at the cellular level and found that two drugs reduced development of blood clots in mice affected with the condition.